Akshay Amaraneni

Dr. Akshay Amaraneni

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2017 in Current Hematologic Malignancy Reports
Verified
Journal Article
Closed access
PDF file
UZUmar Zahid
Umar Zahid
FAFaisal Akbar
Faisal Akbar
AAAkshay Amaraneni
Akshay Amaraneni
MHMuhammad Husnain
Muhammad Husnain
OCOnyee Chan
Onyee Chan
FAFaiz Anwwer
Faiz Anwwer

1 May 2012 in Neuropsychology
Verified
Journal Article
Closed access
BHBenjamin M. Hampstead
Benjamin M. Hampstead
KSKrish Sathian
Krish Sathian
PPPamela A. Phillips
Pamela A. Phillips
AAAkshay Amaraneni
Akshay Amaraneni
WDWilliam R. Delaune
William R. Delaune
ASAnthony Y. Stringer
Anthony Y. Stringer
To evaluate the efficacy of mnemonic strategy training versus a matched-exposure control condition and to examine the relationship between training-related gains, neuropsychological abilities, and medial temporal lobe volumetrics in patients with amnestic mild cognitive impairment (aMCI) and age-matched healthy controls. Twenty-three of 45 screened healthy controls and 29 of 42 screened patients with aMCI were randomized to mnemonic strategy or matched-exposure groups. Groups were run in parallel, with participants blind to the other intervention. All participants completed five sessions within 2 weeks. Memory testing for object-location associations (OLAs) was performed during sessions one and five and at a 1-month follow-up. During Sessions 2-4, participants received either mnemonic strategy training or a matched number of exposures with corrective feedback for a total of 45 OLAs. Structural magnetic resonance imaging was performed in most participants, and medial temporal lobe volumetrics were acquired. Twenty-one healthy controls and 28 patients with aMCI were included in data analysis. Mnemonic strategy training was significantly more beneficial than matched exposure immediately after training, p = .006, partial η2 = .16, and at 1 month, p < .001, partial η2 = .35, regardless of diagnostic group (healthy group or aMCI group). Although patients with aMCI demonstrated gains comparable to the healthy control groups, their overall performance generally remained reduced. Mnemonic strategy-related improvement was correlated positively with baseline memory and executive functioning and negatively with inferior lateral ventricle volume in patients with aMCI; no significant relationships were evident in matched-exposure patients. Mnemonic strategies effectively improve memory for specific content for at least 1 month in patients with aMCI.

1 July 2011 in Neuropsychologia
Verified
Journal Article
Closed access
BHBenjamin M. Hampstead
Benjamin M. Hampstead
ASAnthony Y. Stringer
Anthony Y. Stringer
RSRandall F. Stilla
Randall F. Stilla
AAAkshay Amaraneni
Akshay Amaraneni
KSK. Sathian
K. Sathian

Verified
Journal Article
Open access
PDF file
MMMuftah Mahmud
Muftah Mahmud
SVSwati Vasireddy
Swati Vasireddy
KGKrisstina Gowin
Krisstina Gowin
AAAkshay Amaraneni
Akshay Amaraneni
Myelofibrosis (MF), Myeloproliferative neoplasms (MPNs), and MDS/MPN overlap syndromes have a broad range of clinical presentations and molecular abnormalities, making their diagnosis and classification complex. This paper reviews molecular aberration, epigenetic modifications, chromosomal anomalies, and their interactions with cellular and other immune mechanisms in the manifestations of these disease spectra, clinical features, classification, and treatment modalities. The advent of new-generation sequencing has broadened the understanding of the genetic factors involved. However, while great strides have been made in the pharmacological treatment of these diseases, treatment of advanced disease remains hematopoietic stem cell transplant.

24 March 2016 in IDCases
Verified
Journal Article
Open access
PDF file
DMDevin Malik
Devin Malik
AAAkshay Amaraneni
Akshay Amaraneni
SSSukhpreet Singh
Sukhpreet Singh
RRRichard Roach
Richard Roach
Canine heartworm, Dirofilaria immitis, is a nematode parasite that infects dogs by way of mosquito bite. Rarely, humans play accidental hosts to this parasite and are not a suitable environment for the nematode to live. As the parasite dies in the pulmonary vessels it embolizes the vessels causing infarction and eventual nodule formation in the lungs. In the right clinical context, a nodule can be considered malignant prompting invasive tissue sampling. We describe a case of a 48-year-old man who was found to have multiple asymptomatic scattered pulmonary nodules during imaging workup for an insulinoma. Fine needle biopsy of the largest nodule revealed a necrotic granuloma, lab testing and culture ruled out fungal and bacterial causes. Clinically, this picture was consistent with D. immitis infection.

7 May 2015 in Case Reports in Infectious Diseases
Verified
Journal Article
Open access
PDF file
AAAkshay Amaraneni
Akshay Amaraneni
DMDevin Malik
Devin Malik
SJSakshi Jasra
Sakshi Jasra
SCSreenivasa R. Chandana
Sreenivasa R. Chandana
DGDeepak Garg
Deepak Garg
TheKytococcusgenus formerly belonged toMicrococcus. The first report of aKytococcus schroeteriinfection was in 2002 in a patient diagnosed with endocarditis. We report a case of central line associatedKytococcus schroeteribacteremia in a patient with underlying Hairy Cell Leukemia.Kytococcus schroeteriis an emerging infection in the neutropenic population and in patients with implanted artificial tissue. It is thought to be a commensal bacterium of the skin; however, attempts to culture the bacteria remain unsuccessful. There have been a total of 5 cases (including ours) ofK. schroeteribacteremia in patients with hematologic malignancies and neutropenia and only 18 documented cases in any population. Four of the cases of bacteria in neutropenic patients have been fatal, but early detection and treatment could make a difference in clinical outcomes.